Literature DB >> 15104942

[Validation of the Pneumonia Severity Index for hospitalizing patients with community-acquired pneumonia].

José M Querol-Ribelles1, José M Tenías, José M Querol-Borrás, Damiana González-Granda, Manuel Hernández, Rosa Ferreruela, Isidoro Martínez.   

Abstract

BACKGROUND AND
OBJECTIVE: Our main objective was to assess the utility of the Pneumonia Severity Index (PSI) to decide the site of care home or hospital of patients with community-acquired pneumonia (CAP). PATIENTS AND
METHOD: All CAP patients who came to the emergency department from 1 January to 31 December, 2000, were prospectively assessed with a protocol based on the PSI and additional admission criteria applied to classes I, II and III. Mortality within 30 days and poor outcome were used as endpoints. We tested the diagnostic efficacy of the PSI scale in predicting mortality or unfavourable events by calculating the area below the ROC curve.
RESULTS: Of the 243 CAP patients included, 124 (51%) belonged to classes I, II and III, and 119 (49%) belonged to classes IV and V. One hundred and fifty six (64%) patients were admitted. Fifteen (6.2%) patients died, all of them belonging to classes IV and V. Forty four (18%) patients showed a poor outcome. Only one patient who was initially sent home had a poor outcome. The prognostic value of the PSI scale to predict mortality (ROC = 0.92; CI 95%, 0.88-0.95) was high.
CONCLUSIONS: Our results confirm that the PSI scale is a good prognostic index in clinical practice for predicting mortality due to CAP. In order to use the PSI to decide the site of care of patients with CAP, not only the score obtained but also additional factors should be taken into account.

Entities:  

Mesh:

Year:  2004        PMID: 15104942     DOI: 10.1016/s0025-7753(04)74282-7

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study.

Authors:  Marta Sardà Sánchez; Joan Calzada Hernández; Susanna Hernández-Bou; Gemma Claret Teruel; Jesús Velasco Rodríguez; Carles Luaces Cubells
Journal:  BMC Res Notes       Date:  2012-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.